Pacific Biosciences of California (PACB) — Cash Flow-to-Debt Ratio
Pacific Biosciences of California (PACB) has a Cash Flow-to-Debt Ratio of -0.06x as of March 2026, meaning its operating cash flow of $-44.69 Million could theoretically repay 0% of its total liabilities ($780.00 Million) in one year. Check PACB total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Pacific Biosciences of California Cash Flow-to-Debt Ratio (2008–2025)
Historical debt coverage capacity for Pacific Biosciences of California across 18 annual periods. Also explore PACB asset base for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Pacific Biosciences of California (2008–2025)
Year-by-year debt coverage analysis for Pacific Biosciences of California. For market capitalisation and broader financial context, see market cap of Pacific Biosciences of California.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.14x | $-111.21 Million | $778.73 Million | ▲ +47.8% |
| 2024 | -0.27x | $-206.06 Million | $753.85 Million | ▼ -7.1% |
| 2023 | -0.26x | $-266.55 Million | $1.04 Billion | ▼ -16.7% |
| 2022 | -0.22x | $-263.21 Million | $1.20 Billion | ▼ -139.1% |
| 2021 | -0.09x | $-111.18 Million | $1.22 Billion | ▼ -136.8% |
| 2020 | 0.25x | $19.50 Million | $78.49 Million | ▲ +129.5% |
| 2019 | -0.84x | $-78.31 Million | $93.07 Million | ▲ +28.8% |
| 2018 | -1.18x | $-66.43 Million | $56.21 Million | ▼ -1.5% |
| 2017 | -1.16x | $-67.52 Million | $57.98 Million | ▲ +8.8% |
| 2016 | -1.28x | $-67.93 Million | $53.22 Million | ▼ -53.4% |
| 2015 | -0.83x | $-47.89 Million | $57.57 Million | ▼ -12.5% |
| 2014 | -0.74x | $-51.47 Million | $69.57 Million | ▼ -66.2% |
| 2013 | -0.45x | $-29.83 Million | $67.00 Million | ▲ +88.2% |
| 2012 | -3.78x | $-76.82 Million | $20.30 Million | ▲ +1.3% |
| 2011 | -3.83x | $-102.97 Million | $26.85 Million | ▲ +18.6% |
| 2010 | -4.71x | $-122.00 Million | $25.88 Million | ▼ -1652.4% |
| 2009 | -0.27x | $-74.84 Million | $278.22 Million | ▼ -45.0% |
| 2008 | -0.19x | $-38.30 Million | $206.50 Million | — |